SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-005432
Filing Date
2021-01-19
Accepted
2021-01-19 17:17:34
Documents
1
Group Members
PARAG SAXENARAHUL NAYAR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm213579d2_sc13da.htm SC 13D/A 72877
  Complete submission text file 0001104659-21-005432.txt   74522
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 21536360
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
Tenzing LLC (Filed by) CIK: 0001744957 (see all company filings)

IRS No.: 825254005 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A